1. Campath-1H (anti-CD52) monoclonal antibody therapy in lymphoproliferative disorders

   • G. A. Pangalis
   • M. N. Dimopoulou
   • M. P. Siakantaris

   Review Pages: 99 - 107

2. Serum S100β protein as a marker of disease activity in patients with malignant melanoma

   • Muneeruddin Q. Mohammed
   • Hagosa D. Abraha
   • Spyros Retsas

   Original Article Pages: 109 - 120

3. Treatment of the T98G glioblastoma cell line with antisense oligonucleotides directed toward mRNA encoding transforming growth factor-α and the epidermal growth factor receptor

   • Marvin Rubenstein
   • Roberta Glick
   • Patrick Guinan

   Original Article Pages: 121 - 130

4. Prevention of delayed emesis induced by moderately emetogenic chemotherapy in patients with acute emesis

   • D. Santini
   • B. Vincenzi
   • G. Tonini

   Original Article Pages: 131 - 135

5. Reproducibility of tumor response evaluation in patients with high-grade malignant non-hodgkin’s lymphoma

   • Eva Ösby
   • Adam Taube
   • Magnus Björkholm

   Original Article Pages: 137 - 140

6. Rituximab (Mabthera™, rituxan™) in patients with recurrent indolent lymphoma

   • J. Walewski
   • E. Kraszewska
   • the Polish Lymphoma Research Group

   Original Article Pages: 141 - 148

7. Tumor lysis syndrome in small cell lung cancer

   • Andre M. Kallab
   • Anand P. Jillella

   Case Report Pages: 149 - 151

8. Bilateral chylothorax due to retrosternal goiter in a patient with non-hodgkin’s lymphoma

   • Marcus Simmgen
   • Edward S. Newlands
   • David M. Vigushin

   Case Report Pages: 153 - 157

9. Metastases in small thickness oral squamous-cell carcinoma arising in oral lichen planus

   • Michele D. Mignogna
   • Lorenzo Lo Muzio
   • Eduardo Bucci

   Case Report Pages: 159 - 163

10. Choriocarcinoma of the gallbladder

    • Jen C. Wang
    • Santos Angeles
    • Nagabhushana Nimmagadda

    Case Report Pages: 165 - 169